BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999;29:719-27. [PMID: 10051473 DOI: 10.1002/hep.510290307] [Cited by in Crossref: 192] [Cited by in F6Publishing: 169] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Ali Mondal S, Sathiaseelan R, Mann SN, Kamal M, Luo W, Saccon TD, Isola JVV, Peelor FF 3rd, Li T, Freeman WM, Miller BF, Stout MB. 17α-estradiol, a lifespan-extending compound, attenuates liver fibrosis by modulating collagen turnover rates in male mice. Am J Physiol Endocrinol Metab 2023;324:E120-34. [PMID: 36516471 DOI: 10.1152/ajpendo.00256.2022] [Reference Citation Analysis]
2 Zhao M, Ma L, Honda T, Kato A, Ohshiro T, Yokoyama S, Yamamoto K, Ito T, Imai N, Ishizu Y, Nakamura M, Kawashima H, Tsuji NM, Ishigami M, Fujishiro M. Astaxanthin Attenuates Nonalcoholic Steatohepatitis with Downregulation of Osteoprotegerin in Ovariectomized Mice Fed Choline-Deficient High-Fat Diet. Dig Dis Sci 2023;68:155-63. [PMID: 35397697 DOI: 10.1007/s10620-022-07489-6] [Reference Citation Analysis]
3 Mahboobifard F, Pourgholami MH, Jorjani M, Dargahi L, Amiri M, Sadeghi S, Tehrani FR. Estrogen as a key regulator of energy homeostasis and metabolic health. Biomedicine & Pharmacotherapy 2022;156:113808. [DOI: 10.1016/j.biopha.2022.113808] [Reference Citation Analysis]
4 Kamiya A, Ida K. Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6. Cells 2022;11. [PMID: 36497010 DOI: 10.3390/cells11233751] [Reference Citation Analysis]
5 Kuang M, Sheng G, Hu C, Lu S, Peng N, Zou Y. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease. Lipids Health Dis 2022;21:104. [PMID: 36266655 DOI: 10.1186/s12944-022-01717-8] [Reference Citation Analysis]
6 Yang H, Chen G, Zhou M, Xie L, Jin Y, Chen H, Chen Z, Kong Y, Yuan C, Li Z. Association of age at first birth and risk of non-alcoholic fatty liver disease in women: evidence from the NHANES. Hepatol Int. [DOI: 10.1007/s12072-022-10429-1] [Reference Citation Analysis]
7 Xu L, Yuan Y, Che Z, Tan X, Wu B, Wang C, Xu C, Xiao J. The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones. Front Immunol 2022;13:939631. [DOI: 10.3389/fimmu.2022.939631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Mondal SA, Sathiaseelan R, Mann SN, Kamal M, Luo W, Saccon TD, Isola JV, Peelor FF, Li T, Freeman WM, Miller BF, Stout MB. 17α-estradiol, a lifespan-extending compound, attenuates liver fibrosis by modulating collagen turnover rates in male mice.. [DOI: 10.1101/2022.06.16.496423] [Reference Citation Analysis]
9 Montefusco D, Jamil M, Maczis MA, Schroeder W, Levi M, Ranjit S, Allegood J, Bandyopadhyay D, Retnam R, Spiegel S, Cowart LA. Sphingosine Kinase 1 Mediates Sexual Dimorphism in Fibrosis in a Mouse Model of NASH. Mol Metab 2022;:101523. [PMID: 35671973 DOI: 10.1016/j.molmet.2022.101523] [Reference Citation Analysis]
10 Sandovici I, Fernandez-Twinn DS, Hufnagel A, Constância M, Ozanne SE. Sex differences in the intergenerational inheritance of metabolic traits. Nat Metab 2022;4:507-23. [PMID: 35637347 DOI: 10.1038/s42255-022-00570-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
11 Kim W. Chronic Liver Disease. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_14] [Reference Citation Analysis]
12 Jiang X, Li L, Xue HY. The impact of body position and exercise on the measurement of liver Young's modulus by real-time shear wave elastography. Technol Health Care 2021. [PMID: 34657862 DOI: 10.3233/THC-213218] [Reference Citation Analysis]
13 Tobari M, Hashimoto E. Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. Gut Liver 2020;14:537-45. [PMID: 31887811 DOI: 10.5009/gnl19236] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
14 Vilar-Gomez E, Pirola CJ, Sookoian S, Wilson LA, Liang T, Chalasani N. The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD. Clin Transl Gastroenterol 2021;12:e00400. [PMID: 34506332 DOI: 10.14309/ctg.0000000000000400] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Königshofer P, Brusilovskaya K, Petrenko O, Hofer BS, Schwabl P, Trauner M, Reiberger T. Nuclear Receptors in Liver Fibrosis. Biochim Biophys Acta Mol Basis Dis 2021;:166235. [PMID: 34339839 DOI: 10.1016/j.bbadis.2021.166235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
16 Carruba G. Estrogens in Hepatocellular Carcinoma: Friends or Foes? Cancers (Basel) 2021;13:2085. [PMID: 33925807 DOI: 10.3390/cancers13092085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lu J, Gong Y, Wei X, Yao Z, Yang R, Xin J, Gao L, Shao S. Changes in hepatic triglyceride content with the activation of ER stress and increased FGF21 secretion during pregnancy. Nutr Metab (Lond) 2021;18:40. [PMID: 33849585 DOI: 10.1186/s12986-021-00570-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gianos E, Karalis DG, Gaballa D, Paparodis R, Mintz GL, Balakrishnan M, Myerson M, Brinton EA, Wild RA. Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. J Clin Lipidol 2021;15:423-30. [PMID: 33836983 DOI: 10.1016/j.jacl.2021.03.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Shen M, Xu M, Zhong F, Crist MC, Prior AB, Yang K, Allaire DM, Choueiry F, Zhu J, Shi H. A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2. Cells 2021;10:455. [PMID: 33672651 DOI: 10.3390/cells10020455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
20 Sarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP, Afshar Y, Terrault NA. Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:318-65. [PMID: 32946672 DOI: 10.1002/hep.31559] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
21 Degasperi E, Colombo M. Natural History of Hepatitis C Infection. Hepatitis C: Epidemiology, Prevention and Elimination 2021. [DOI: 10.1007/978-3-030-64649-3_7] [Reference Citation Analysis]
22 Samadi-Noshahr Z, Hadjzadeh MA, Moradi-Marjaneh R, Khajavi-Rad A. The hepatoprotective effects of fennel seeds extract and trans-Anethole in streptozotocin-induced liver injury in rats. Food Sci Nutr 2021;9:1121-31. [PMID: 33598196 DOI: 10.1002/fsn3.2090] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
23 Li DK, Khan MR, Wang Z, Chongsrisawat V, Swangsak P, Teufel-Schäfer U, Engelmann G, Goldschmidt I, Baumann U, Tokuhara D, Cho Y, Rowland M, Mjelle AB, Ramm GA, Lewindon PJ, Witters P, Cassiman D, Ciuca IM, Prokop LD, Haffar S, Corey KE, Murad MH, Furuya KN, Bazerbachi F. Normal liver stiffness and influencing factors in healthy children: An individual participant data meta-analysis. Liver Int 2020;40:2602-11. [PMID: 32901449 DOI: 10.1111/liv.14658] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
24 Seo D, Lee Y, Park S, Choi Y, Huh B, Lee E, Huh K, Kim S, Cha B. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes. Diabetes & Metabolism 2020;46:362-9. [DOI: 10.1016/j.diabet.2019.10.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
25 Xiong M, Li J, Yang S, Zeng F, Ji Y, Liu J, Wu Q, He Q, Jiang R, Zhou F, Wen W, Chen J, Hou J. Influence of Gender and Reproductive Factors on Liver Fibrosis in Patients With Chronic Hepatitis B Infection. Clin Transl Gastroenterol 2019;10:e00085. [PMID: 31651450 DOI: 10.14309/ctg.0000000000000085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
26 Kay C, Stilwell K, Aden J, Morales‐cardona A. Surgical menopause may not increase the risk of non‐alcoholic fatty liver disease. GastroHep 2020;2:240-246. [DOI: 10.1002/ygh2.422] [Reference Citation Analysis]
27 Yuan L, Kardashian A, Sarkar M. NAFLD in women: Unique pathways, biomarkers and therapeutic opportunities. Curr Hepatol Rep 2019;18:425-32. [PMID: 32523869 DOI: 10.1007/s11901-019-00495-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
28 Venetsanaki V, Polyzos SA. Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives. Curr Vasc Pharmacol. 2019;17:546-555. [PMID: 29992886 DOI: 10.2174/1570161116666180711121949] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 10.3] [Reference Citation Analysis]
29 Zhang M, Wang Y, Zhu G, Sun C, Wang J. Hepatoprotective effect and possible mechanism of phytoestrogen calycosin on carbon tetrachloride-induced liver fibrosis in mice. Naunyn Schmiedebergs Arch Pharmacol 2021;394:189-204. [PMID: 32474674 DOI: 10.1007/s00210-020-01891-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
30 Kandemir B, Ates S, Kurutas EB, Durduran Y, Erayman I, Bitirgen M. GPER-1 in chronic hepatitis B. Journal of Radiation Research and Applied Sciences 2020;13:546-51. [DOI: 10.1080/16878507.2020.1762527] [Reference Citation Analysis]
31 Zhou IY, Clavijo Jordan V, Rotile NJ, Akam E, Krishnan S, Arora G, Krishnan H, Slattery H, Warner N, Mercaldo N, Farrar CT, Wellen J, Martinez R, Schlerman F, Tanabe KK, Fuchs BC, Caravan P. Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis. Radiology 2020;296:67-75. [PMID: 32343209 DOI: 10.1148/radiol.2020192118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
32 Garate-Carrillo A, Gonzalez J, Ceballos G, Ramirez-Sanchez I, Villarreal F. Sex related differences in the pathogenesis of organ fibrosis. Transl Res 2020;222:41-55. [PMID: 32289256 DOI: 10.1016/j.trsl.2020.03.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
33 Jain V, Poddar U, Negi TS, Saraswat VA, Krishnani N, Yachha SK, Srivastava A. Utility and accuracy of transient elastography in determining liver fibrosis: a case-control study. Eur J Pediatr 2020;179:671-7. [PMID: 31960149 DOI: 10.1007/s00431-019-03561-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Colombo D, Zullo A, Simoni L, Zagni E; SURF Study Group. The SURF (Italian observational study for renal insufficiency evaluation in liver transplant recipients): a post-hoc between-sex analysis. BMC Nephrol 2019;20:475. [PMID: 31870321 DOI: 10.1186/s12882-019-1656-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
35 Yang H, Sun Y, Tang Y, Lu Y, Hu B, Ying T. Shear-wave elastography of the liver in a healthy pediatric population. J Clin Ultrasound 2020;48:139-44. [PMID: 31846085 DOI: 10.1002/jcu.22794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF, Suzuki A. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology 2019;70:1457-69. [PMID: 30924946 DOI: 10.1002/hep.30626] [Cited by in Crossref: 343] [Cited by in F6Publishing: 324] [Article Influence: 85.8] [Reference Citation Analysis]
37 Soria-Jasso LE, Cariño-Cortés R, Muñoz-Pérez VM, Pérez-Hernández E, Pérez-Hernández N, Fernández-Martínez E. Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver. Int J Mol Sci 2019;20:E4694. [PMID: 31546715 DOI: 10.3390/ijms20194694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
38 Park SH, Park YE, Lee J, Choi JH, Heo NY, Park J, Kim TO, Moon YS, Kim HK, Jang HJ, Park HY, Jeong C, Suk KT, Kim DJ. Lack of association between early menopause and non-alcoholic fatty liver disease in postmenopausal women. Climacteric 2020;23:173-7. [DOI: 10.1080/13697137.2019.1650018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Mosley GE, Hoy RC, Nasser P, Kaseta T, Lai A, Evashwick-Rogler TW, Lee M, Iatridis JC. Sex Differences in Rat Intervertebral Disc Structure and Function Following Annular Puncture Injury. Spine (Phila Pa 1976) 2019;44:1257-69. [PMID: 30973506 DOI: 10.1097/BRS.0000000000003055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
40 Grossmann M, Wierman ME, Angus P, Handelsman DJ. Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. Endocr Rev 2019;40:417-46. [PMID: 30500887 DOI: 10.1210/er.2018-00158] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 10.3] [Reference Citation Analysis]
41 Lee YH, Son JY, Kim KS, Park YJ, Kim HR, Park JH, Kim KB, Lee KY, Kang KW, Kim IS, Kacew S, Lee BM, Kim HS. Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats. Int J Mol Sci 2019;20:E3709. [PMID: 31362375 DOI: 10.3390/ijms20153709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
42 Marchisello S, Di Pino A, Scicali R, Urbano F, Piro S, Purrello F, Rabuazzo AM. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. Int J Mol Sci 2019;20:E1948. [PMID: 31010049 DOI: 10.3390/ijms20081948] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 22.5] [Reference Citation Analysis]
43 Li S, Ghoshal S, Sojoodi M, Arora G, Masia R, Erstad DJ, Lanuti M, Hoshida Y, Baumert TF, Tanabe KK, Fuchs BC. Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis. J Gastrointest Surg 2019;23:101-11. [PMID: 30367397 DOI: 10.1007/s11605-018-4004-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
44 Dowla SA, Goss AM, Ashraf AP. Nonalcoholic Fatty Liver Disease in Children with Obesity. Global Perspectives on Childhood Obesity 2019. [DOI: 10.1016/b978-0-12-812840-4.00020-7] [Reference Citation Analysis]
45 Deng T, Liu J, Zhang M, Wang Y, Zhu G, Wang J. Inhibition effect of phytoestrogen calycosin on TGF-β 1 -induced hepatic stellate cell activation, proliferation, and migration via estrogen receptor β. Can J Physiol Pharmacol 2018;96:1268-75. [DOI: 10.1139/cjpp-2018-0474] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
46 Buettner N, Thimme R. Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma. Semin Immunopathol 2019;41:203-11. [PMID: 30498927 DOI: 10.1007/s00281-018-0727-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
47 Shen M, Cao J, Shi H. Effects of Estrogen and Estrogen Receptors on Transcriptomes of HepG2 Cells: A Preliminary Study Using RNA Sequencing. Int J Endocrinol 2018;2018:5789127. [PMID: 30510575 DOI: 10.1155/2018/5789127] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
48 Mulabecirovic A, Mjelle AB, Gilja OH, Vesterhus M, Havre RF. Liver elasticity in healthy individuals by two novel shear-wave elastography systems-Comparison by age, gender, BMI and number of measurements. PLoS One. 2018;13:e0203486. [PMID: 30216377 DOI: 10.1371/journal.pone.0203486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
49 Musavi SAA, Yamashita S, Fujihara T, Masaka H, Islam MR, Kim S, Gotoh T, Kawahara M, Tashiro K, Yamauchi N. Analysis of differentially expressed genes and the promoters in bovine endometrium throughout estrus cycle and early pregnancy. Anim Sci J 2018;89:1609-21. [PMID: 30182475 DOI: 10.1111/asj.13091] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
50 Sarkar M, Dodge JL, Greenblatt RM, Kuniholm MH, DeHovitz J, Plankey M, Kovacs A, French AL, Seaberg EC, Ofotokun I, Fischl M, Overton E, Kelly E, Bacchetti P, Peters MG; Women’s Interagency HIV Study. Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women. Clin Infect Dis 2017;65:1695-702. [PMID: 29020239 DOI: 10.1093/cid/cix643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
51 Yamanaka Y, Menuki K, Tajima T, Okada Y, Kosugi K, Zenke Y, Sakai A. Effect of estradiol on fibroblasts from postmenopausal idiopathic carpal tunnel syndrome patients. J Cell Physiol 2018;233:8723-30. [PMID: 29781507 DOI: 10.1002/jcp.26752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
52 Choi E, Kim W, Joo SK, Park S, Park JH, Kang YK, Jin SY, Chang MS. Expression patterns of STAT3, ERK and estrogen-receptor α are associated with development and histologic severity of hepatic steatosis: a retrospective study. Diagn Pathol 2018;13:23. [PMID: 29615085 DOI: 10.1186/s13000-018-0698-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
53 Shao S, Yao Z, Lu J, Song Y, He Z, Yu C, Zhou X, Zhao L, Zhao J, Gao L. Ablation of prolactin receptor increases hepatic triglyceride accumulation. Biochem Biophys Res Commun. 2018;498:693-699. [PMID: 29524401 DOI: 10.1016/j.bbrc.2018.03.048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
54 Que R, Shen Y, Ren J, Tao Z, Zhu X, Li Y. Estrogen receptor‑β‑dependent effects of saikosaponin‑d on the suppression of oxidative stress‑induced rat hepatic stellate cell activation. Int J Mol Med 2018;41:1357-64. [PMID: 29286085 DOI: 10.3892/ijmm.2017.3349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
55 Wang YH, Li RK, Fu Y, Li J, Yang XM, Zhang YL, Zhu L, Yang Q, Gu JR, Xing X, Zhang ZG. Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10. J Immunol Res 2017;2017:3072745. [PMID: 29464186 DOI: 10.1155/2017/3072745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
56 Hassan MM, Botrus G, Abdel-Wahab R, Wolff RA, Li D, Tweardy D, Phan AT, Hawk E, Javle M, Lee JS, Torres HA, Rashid A, Lenzi R, Hassabo HM, Abaza Y, Shalaby AS, Lacin S, Morris J, Patt YZ, Amos CI, Khaderi SA, Goss JA, Jalal PK, Kaseb AO. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol 2017;15:1791-9. [PMID: 28579181 DOI: 10.1016/j.cgh.2017.05.036] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
57 Kramer JR, El-Serag HB, Taylor TJ, White DL, Asch SM, Frayne SM, Cao Y, Smith DL, Kanwal F. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study. J Viral Hepat 2017;24:955-65. [PMID: 28815822 DOI: 10.1111/jvh.12728] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Rani V, Verma Y, Rana K, Rana SVS. Zinc oxide nanoparticles inhibit dimethylnitrosamine induced liver injury in rat. Chem Biol Interact 2018;295:84-92. [PMID: 29024620 DOI: 10.1016/j.cbi.2017.10.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
59 Wang D, Zhang P, Zhang M. Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase. Exp Ther Med 2017;14:5363-70. [PMID: 29285064 DOI: 10.3892/etm.2017.5219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
60 Lee JE, Shin KS, Cho JS, You SK, Min JH, Kim KH, Song IS, Cheon KS. Non-invasive Assessment of Liver Fibrosis with ElastPQ: Comparison with Transient Elastography and Serologic Fibrosis Marker Tests, and Correlation with Liver Pathology Results. Ultrasound Med Biol 2017;43:2515-21. [PMID: 28844464 DOI: 10.1016/j.ultrasmedbio.2017.07.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
61 Nishimura S, Teshima A, Kawabata F, Tabata S. Estradiol inhibits hepatic stellate cell area and collagen synthesis in the chicken liver. Anim Sci J 2017;88:1827-34. [PMID: 28574635 DOI: 10.1111/asj.12830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Adv Ther 2017;34:1291-326. [PMID: 28526997 DOI: 10.1007/s12325-017-0556-1] [Cited by in Crossref: 264] [Cited by in F6Publishing: 236] [Article Influence: 44.0] [Reference Citation Analysis]
63 Collazos J, Valle-Garay E, Suárez-Zarracina T, Montes AH, Cartón JA, Asensi V. Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients. World J Virol 2017; 6(2): 36-45 [PMID: 28573088 DOI: 10.5501/wjv.v6.i2.36] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
64 Urlep Ž, Lorbek G, Perše M, Jeruc J, Juvan P, Matz-Soja M, Gebhardt R, Björkhem I, Hall JA, Bonneau R, Littman DR, Rozman D. Disrupting Hepatocyte Cyp51 from Cholesterol Synthesis Leads to Progressive Liver Injury in the Developing Mouse and Decreases RORC Signalling. Sci Rep 2017;7:40775. [PMID: 28098217 DOI: 10.1038/srep40775] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
65 Lee JM, Seo YS, Kim TH, Ahn JM, Yim SY, Kim SU, Jung YK, Kim JH, An H, Yim HJ, Yeon JE, Lee HS, Byun KS, Um SH, Kim CD, Ryu HS. The LAW index as an accurate indicator of the initiation of antiviral treatment in patients with chronic hepatitis B. J Gastroenterol Hepatol 2017;32:208-14. [PMID: 27194632 DOI: 10.1111/jgh.13447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
66 Conti F, Vukotic R, Foschi FG, Domenicali M, Giacomoni P, Savini S, Lanzi A, Dall'Aglio AC, Saini G, Matroroberto M, Bernardi M, Stefanini GF, Andreone P. Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study. Dig Liver Dis 2016;48:1357-63. [PMID: 27522549 DOI: 10.1016/j.dld.2016.07.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
67 Tziotzios C, Stefanato CM, Fenton DA, Simpson MA, Mcgrath JA. Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis. Exp Dermatol 2016;25:847-52. [DOI: 10.1111/exd.13071] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
68 Klair JS, Yang JD, Abdelmalek MF, Guy CD, Gill RM, Yates K, Unalp-Arida A, Lavine JE, Clark JM, Diehl AM, Suzuki A; Nonalcoholic Steatohepatitis Clinical Research Network. A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease. Hepatology 2016;64:85-91. [PMID: 26919573 DOI: 10.1002/hep.28514] [Cited by in Crossref: 96] [Cited by in F6Publishing: 96] [Article Influence: 13.7] [Reference Citation Analysis]
69 Temple JL, Cordero P, Li J, Nguyen V, Oben JA. A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence. Int J Mol Sci 2016;17:E947. [PMID: 27314342 DOI: 10.3390/ijms17060947] [Cited by in Crossref: 96] [Cited by in F6Publishing: 109] [Article Influence: 13.7] [Reference Citation Analysis]
70 Ge S, Xie J, Liu F, He J, He J. MicroRNA-19b reduces hepatic stellate cell proliferation by targeting GRB2 in hepatic fibrosis models in vivo and in vitro as part of the inhibitory effect of estradiol. J Cell Biochem 2015;116:2455-64. [PMID: 25650006 DOI: 10.1002/jcb.25116] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
71 Corsi DJ, Karges W, Thavorn K, Crawley AM, Cooper CL. Influence of female sex on hepatitis C virus infection progression and treatment outcomes. Eur J Gastroenterol Hepatol 2016;28:405-11. [PMID: 26745470 DOI: 10.1097/MEG.0000000000000567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
72 Shen M, Shi H. Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells. PLoS One 2016;11:e0151455. [PMID: 26982332 DOI: 10.1371/journal.pone.0151455] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
73 Petta S, Valenti L, Bugianesi E, Targher G, Bellentani S, Bonino F; Special Interest Group on Personalised Hepatology of the Italian Association for the Study of the Liver (AISF), Special Interest Group on Personalised Hepatology of Italian Association for Study of Liver AISF. A "systems medicine" approach to the study of non-alcoholic fatty liver disease. Dig Liver Dis 2016;48:333-42. [PMID: 26698409 DOI: 10.1016/j.dld.2015.10.027] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
74 Marcos R, Lopes C, Malhão F, Correia-Gomes C, Fonseca S, Lima M, Gebhardt R, Rocha E. Stereological assessment of sexual dimorphism in the rat liver reveals differences in hepatocytes and Kupffer cells but not hepatic stellate cells. J Anat 2016;228:996-1005. [PMID: 26892301 DOI: 10.1111/joa.12448] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
75 Ghany MG, Liang TJ. Natural History of Chronic Hepatitis C. Hepatitis C Virus II 2016. [DOI: 10.1007/978-4-431-56101-9_1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Seo YS, Kim MY, Kim SU, Hyun BS, Jang JY, Lee JW, Lee JI, Suh SJ, Park SY, Park H, Jung EU, Kim BS, Kim IH, Lee TH, Um SH, Han KH, Kim SG, Paik SK, Choi JY, Jeong SW, Jin YJ, Lee KS, Yim HJ, Tak WY, Hwang SG, Lee YJ, Lee CH, Kim DG, Kang YW, Kim YS; Korean Transient Elastography Study Group. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study. Liver Int 2015;35:2246-55. [PMID: 25682719 DOI: 10.1111/liv.12808] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 6.9] [Reference Citation Analysis]
77 Collazos J, Asensi V, Martin G, Montes AH, Suárez-Zarracina T, Valle-Garay E. The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions. Clin Exp Immunol 2015;182:213-9. [PMID: 26206176 DOI: 10.1111/cei.12686] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
78 Luo F, Ishigami M, Achiwa K, Ishizu Y, Kuzuya T, Honda T, Hayashi K, Ishikawa T, Katano Y, Goto H. Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice. Dig Dis Sci 2015;60:2730-9. [PMID: 25868633 DOI: 10.1007/s10620-015-3660-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
79 Wang SH, Chen PJ, Yeh SH. Gender disparity in chronic hepatitis B: Mechanisms of sex hormones. J Gastroenterol Hepatol 2015;30:1237-45. [PMID: 25708186 DOI: 10.1111/jgh.12934] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
80 Galgenmueller S, Jaeger H, Kratzer W, Schmidt SA, Oeztuerk S, Haenle MM, Mason RA, Graeter T. Parameters affecting different acoustic radiation force impulse applications in the diagnosis of fibrotic liver changes. World J Gastroenterol 2015; 21(27): 8425-8432 [PMID: 26217095 DOI: 10.3748/wjg.v21.i27.8425] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
81 Halász T, Horváth G, Kiss A, Pár G, Szombati A, Gelley F, Nemes B, Kenessey I, Piurkó V, Schaff Z. Evaluation of Histological and non-Invasive Methods for the Detection of Liver Fibrosis: The Values of Histological and Digital Morphometric Analysis, Liver Stiffness Measurement and APRI Score. Pathol Oncol Res 2016;22:1-6. [PMID: 26189126 DOI: 10.1007/s12253-015-9964-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
82 Turola E, Petta S, Vanni E, Milosa F, Valenti L, Critelli R, Miele L, Maccio L, Calvaruso V, Fracanzani AL. Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis. Dis Model Mech. 2015;8:1037-1046. [PMID: 26183212 DOI: 10.1242/dmm.019950] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
83 Brady CW. Liver disease in menopause. World J Gastroenterol 2015; 21(25): 7613-7620 [PMID: 26167064 DOI: 10.3748/wjg.v21.i25.7613] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 74] [Article Influence: 9.4] [Reference Citation Analysis]
84 Rollet-Kurhajec KC, Moodie EE, Walmsley S, Cooper C, Pick N, Klein MB; Canadian Co-infection Cohort Study (CTN 222). Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index. PLoS One 2015;10:e0129868. [PMID: 26090666 DOI: 10.1371/journal.pone.0129868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
85 Alsebaey A, Allam N, Alswat K, Waked I. Normal liver stiffness: A study in living donors with normal liver histology. World J Hepatol 2015; 7(8): 1149-1153 [PMID: 26052404 DOI: 10.4254/wjh.v7.i8.1149] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
86 Alsebaey A. Normal liver stiffness: A study in living donors with normal liver histology. WJH 2015;7:1149. [DOI: 10.4254/wjh.v7.i8.1149] [Reference Citation Analysis]
87 Tian W, Hao C, Fan Z, Weng X, Qin H, Wu X, Fang M, Chen Q, Shen A, Xu Y. Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells. J Hepatol 2015;62:165-74. [PMID: 25109772 DOI: 10.1016/j.jhep.2014.07.029] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 7.3] [Reference Citation Analysis]
88 Alsebaey A. Normal liver stiffness: A study in living donors with normal liver histology. WJH 2015;7:1149. [DOI: 10.4254/wjh.v7.i8.1149] [Cited by in Crossref: 13] [Article Influence: 1.6] [Reference Citation Analysis]
89 Rodríguez-Castro KI, De Martin E, Gambato M, Lazzaro S, Villa E, Burra P. Female gender in the setting of liver transplantation. World J Transplant 2014; 4(4): 229-242 [PMID: 25540733 DOI: 10.5500/wjt.v4.i4.229] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
90 Ohe H, Uchida Y, Yoshizawa A, Hirao H, Taniguchi M, Maruya E, Yurugi K, Hishida R, Maekawa T, Uemoto S, Terasaki PI. Association of Anti-Human Leukocyte Antigen and Anti-Angiotensin II Type 1 Receptor Antibodies With Liver Allograft Fibrosis After Immunosuppression Withdrawal. Transplantation 2014;98:1105-11. [DOI: 10.1097/tp.0000000000000185] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 7.6] [Reference Citation Analysis]
91 Cengiz M, Ozenirler S, Yılmaz G. Estrogen receptor alpha expression and liver fibrosis in chronic hepatitis C virus genotype 1b: a clinicopathological study. Hepat Mon 2014;14:e21885. [PMID: 25368658 DOI: 10.5812/hepatmon.21885] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
92 Wang Z, Xu M, Hu Z, Hultström M, Lai E. Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China. Eur J Gastroenterol Hepatol 2014;26:1015-21. [PMID: 25003744 DOI: 10.1097/MEG.0000000000000151] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
93 Baden R, Rockstroh JK, Buti M. Natural history and management of hepatitis C: does sex play a role? J Infect Dis. 2014;209 Suppl 3:S81-S85. [PMID: 24966194 DOI: 10.1093/infdis/jiu057] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 8.7] [Reference Citation Analysis]
94 Rodrigues MF, Stotzer US, Domingos MM, Deminice R, Shiguemoto GE, Tomaz LM, Sousa NM, Ferreira FC, Leite RD, Selistre-de-Araújo HS, Jordão-Júnior AA, Baldissera V, Perez SE. Effects of ovariectomy and resistance training on oxidative stress markers in the rat liver. Clinics (Sao Paulo) 2013;68:1247-54. [PMID: 24141842 DOI: 10.6061/clinics/2013(09)12] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
95 Guo ZR, Sun DX, Li BS, Liu JX, Li D, Wang JP, Chang LL, Zhou XN, Li MR. Therapeutic effect of collagenase Ⅱ against rat liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2014; 22(13): 1778-1784 [DOI: 10.11569/wcjd.v22.i13.1778] [Reference Citation Analysis]
96 Florentino GS, Cotrim HP, Vilar CP, Florentino AV, Guimarães GM, Barreto VS. Nonalcoholic fatty liver disease in menopausal women. Arq Gastroenterol 2013;50:180-5. [PMID: 24322188 DOI: 10.1590/S0004-28032013000200032] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
97 Yang JD, Abdelmalek MF, Pang H, Guy CD, Smith AD, Diehl AM, Suzuki A. Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 2014;59:1406-14. [PMID: 24123276 DOI: 10.1002/hep.26761] [Cited by in Crossref: 190] [Cited by in F6Publishing: 178] [Article Influence: 21.1] [Reference Citation Analysis]
98 Meer AJ, Maan R, Knegt RJ, Veldt BJ. Natural History of HCV-induced Liver Disease. Curr Hepatitis Rep 2013;12:251-60. [DOI: 10.1007/s11901-013-0195-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
99 Erkan G, Yilmaz G, Cengiz M, Degertekin CK, Akyol G, Ozenirler S. Lack of association of hepatic estrogen receptor-alpha expression with histopathological and biochemical findings in chronic hepatitis C. Pathol Res Pract 2013;209:727-30. [PMID: 24054032 DOI: 10.1016/j.prp.2013.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
100 Castera L. Natural History of Chronic HCV Infection and Non-Invasive Assessment of Hepatic Fibrosis. Viral Hepatitis 2013. [DOI: 10.1002/9781118637272.ch23] [Reference Citation Analysis]
101 Yakimchuk K, Jondal M, Okret S. Estrogen receptor α and β in the normal immune system and in lymphoid malignancies. Mol Cell Endocrinol 2013;375:121-9. [PMID: 23707618 DOI: 10.1016/j.mce.2013.05.016] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
102 Erkan G, Yilmaz G, Konca Degertekin C, Akyol G, Ozenirler S. Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH. Pathol Res Pract 2013;209:429-32. [PMID: 23707549 DOI: 10.1016/j.prp.2013.04.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
103 Burra P, De Martin E, Gitto S, Villa E. Influence of age and gender before and after liver transplantation. Liver Transpl 2013;19:122-34. [PMID: 23172830 DOI: 10.1002/lt.23574] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
104 Van Wettere AJ, Law JM, Hinton DE, Kullman SW. Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injury. Toxicol Pathol 2013;41:744-60. [PMID: 23197195 DOI: 10.1177/0192623312464308] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
105 Ling W, Lu Q, Quan J, Ma L, Luo Y. Assessment of impact factors on shear wave based liver stiffness measurement. Eur J Radiol. 2013;82:335-341. [PMID: 23116805 DOI: 10.1016/j.ejrad.2012.10.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
106 Villa E, Vukotic R, Cammà C, Petta S, Di Leo A, Gitto S, Turola E, Karampatou A, Losi L, Bernabucci V. Reproductive status is associated with the severity of fibrosis in women with hepatitis C. PLoS One. 2012;7:e44624. [PMID: 22970270 DOI: 10.1371/journal.pone.0044624] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
107 Maasoumy B, Wedemeyer H. Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol 2012;26:401-12. [PMID: 23199500 DOI: 10.1016/j.bpg.2012.09.009] [Cited by in Crossref: 163] [Cited by in F6Publishing: 175] [Article Influence: 14.8] [Reference Citation Analysis]
108 Suzuki A, Abdelmalek MF, Schwimmer JB, Lavine JE, Scheimann AO, Unalp-Arida A, Yates KP, Sanyal AJ, Guy CD, Diehl AM; Nonalcoholic Steatohepatitis Clinical Research Network. Association between puberty and features of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012;10:786-94. [PMID: 22343513 DOI: 10.1016/j.cgh.2012.01.020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
109 Nishimura S, Teshima A, Chowdhury VS, Tabata S. Changes in collagen fiber content and hepatic stellate cell distribution in the liver of chick embryos and growing chickens. Anim Sci J 2012;83:499-503. [PMID: 22694335 DOI: 10.1111/j.1740-0929.2011.00986.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
110 Alkiyumi SS, Abdullah MA, Alrashdi AS, Salama SM, Abdelwahab SI, Hadi AH. Ipomoea aquatica extract shows protective action against thioacetamide-induced hepatotoxicity. Molecules 2012;17:6146-55. [PMID: 22617138 DOI: 10.3390/molecules17056146] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
111 Kim BK, Kim SU, Choi GH, Han WK, Park MS, Kim EH, Park JY, Kim DY, Choi JS, Yang SC, Choi EH, Song K, Ahn SH, Han KH, Chon CY. "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population. J Gastroenterol Hepatol 2012;27:781-8. [PMID: 22098121 DOI: 10.1111/j.1440-1746.2011.06962.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
112 Yu WJ, Chang CC, Kuo TF, Tsai TC, Chang SJ. Toona sinensis Roem leaf extracts improve antioxidant activity in the liver of rats under oxidative stress. Food Chem Toxicol 2012;50:1860-5. [PMID: 22497899 DOI: 10.1016/j.fct.2012.03.068] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
113 Zhang Y, Wu L, Wang Y, Zhang M, Li L, Zhu D, Li X, Gu H, Zhang CY, Zen K. Protective role of estrogen-induced miRNA -29 expression in carbon tetrachloride-induced mouse liver injury. J Biol Chem. 2012;287:14851-14862. [PMID: 22393047 DOI: 10.1074/jbc.m111.314922] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 7.4] [Reference Citation Analysis]
114 Horie Y, Yamagishi Y, Ebinuma H, Hibi T. Obesity, type 2 diabetes, age, and female gender: significant risk factors in the development of alcoholic liver cirrhosis. Hepatol Int 2013;7:280-5. [DOI: 10.1007/s12072-012-9347-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
115 Ding H, Wu T, Ma K, Wang X, Wu Z, Guo W, Qi J, Ning Q. Noninvasive measurement of liver fibrosis by transient elastography and influencing factors in patients with chronic hepatitis B-A single center retrospective study of 466 patients. J Huazhong Univ Sci Technolog Med Sci 2012;32:69-74. [PMID: 22282248 DOI: 10.1007/s11596-012-0012-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
116 Ellefson WM, Lakner AM, Hamilton A, McKillop IH, Bonkovsky HL, Steuerwald NM, Huet YM, Schrum LW. Neonatal androgenization exacerbates alcohol-induced liver injury in adult rats, an effect abrogated by estrogen. PLoS One 2011;6:e29463. [PMID: 22206017 DOI: 10.1371/journal.pone.0029463] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
117 Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, Grulich-Henn J, Schenk JP, Teufel U. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr 2012;171:353-60. [PMID: 21861093 DOI: 10.1007/s00431-011-1558-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
118 Engelmann G, Gebhardt C, Wenning D, Wühl E, Hoffmann GF, Selmi B, Grulich-Henn J, Schenk JP, Teufel U. Feasibility study and control values of transient elastography in healthy children. Eur J Pediatr. 2012;171:353-360. [PMID: 21861093 DOI: 10.1007/s00431-011-1558-7] [Cited by in Crossref: 98] [Cited by in F6Publishing: 105] [Article Influence: 8.2] [Reference Citation Analysis]
119 Kumar M, Sharma P, Garg H, Kumar R, Bhatia V, Sarin SK. Transient elastographic evaluation in adult subjects without overt liver disease: influence of alanine aminotransferase levels. J Gastroenterol Hepatol 2011;26:1318-25. [PMID: 21443658 DOI: 10.1111/j.1440-1746.2011.06736.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
120 Lai JC, Verna EC, Brown RS Jr, O'Leary JG, Trotter JF, Forman LM, Duman JD, Foster RG, Stravitz RT, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C). Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men. Hepatology 2011;54:418-24. [PMID: 21538434 DOI: 10.1002/hep.24390] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
121 Allina J, Grabowski J, Doherty-Lyons S, Fiel MI, Jackson CE, Zelikoff JT, Odin JA. Maternal allergy acts synergistically with cigarette smoke exposure during pregnancy to induce hepatic fibrosis in adult male offspring. J Immunotoxicol 2011;8:258-64. [PMID: 21718087 DOI: 10.3109/1547691X.2011.589412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
122 Trauner M, Halilbasic E. Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology 2011;140:1120-1125.e1-12. [PMID: 21334334 DOI: 10.1053/j.gastro.2011.02.044] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 6.9] [Reference Citation Analysis]
123 Forde KA, Reddy KR. Hormones: a potential explanation for differences in response rates to therapy for chronic hepatitis C infection. Gastroenterology 2011;140:776-9. [PMID: 21262187 DOI: 10.1053/j.gastro.2011.01.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
124 Cho HJ, Seo YS, Lee KG, Hyun JJ, An H, Keum B, Kim JH, Yim HJ, Jeen YT, Lee HS, Chun HJ, Um SH, Kim CD, Ryu HS. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients. J Gastroenterol Hepatol 2011;26:492-500. [PMID: 21332545 DOI: 10.1111/j.1440-1746.2010.06419.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
125 Baptista PM, Siddiqui MM, Lozier G, Rodriguez SR, Atala A, Soker S. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011;53:604-17. [PMID: 21274881 DOI: 10.1002/hep.24067] [Cited by in Crossref: 483] [Cited by in F6Publishing: 489] [Article Influence: 40.3] [Reference Citation Analysis]
126 Narciso-Schiavon JL, Schiavon Lde L, Carvalho-Filho RJ, Sampaio JP, Batah PN, Barbosa DV, Ferraz ML, Silva AE. Gender influence on treatment of chronic hepatitis C genotype 1. Rev Soc Bras Med Trop 2010;43:217-23. [PMID: 20563484 DOI: 10.1590/s0037-86822010000300001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
127 Chandrasekaran VRM, Periasamy S, Liu L, Liu M. 17β-Estradiol protects against acetaminophen-overdose-induced acute oxidative hepatic damage and increases the survival rate in mice. Steroids 2011;76:118-24. [DOI: 10.1016/j.steroids.2010.09.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
128 Hayashida K, Shoji I, Deng L, Jiang D, Ide Y, Hotta H. 17β-estradiol inhibits the production of infectious particles of hepatitis C virus: 17β-estradiol inhibits HCV virion production. Microbiology and Immunology 2010;54:684-90. [DOI: 10.1111/j.1348-0421.2010.00268.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
129 Koilan S, Hamilton D, Baburyan N, Padala MK, Weber KT, Guntaka RV. Prevention of liver fibrosis by triple helix-forming oligodeoxyribonucleotides targeted to the promoter region of type I collagen gene. Oligonucleotides. 2010;20:231-237. [PMID: 20818932 DOI: 10.1089/oli.2010.0244] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
130 Shin JW, Wang JH, Kim HG, Park HJ, Bok HS, Son CG. CGX, a traditional Korean medicine ameliorates concanavalin A-induced acute liver injury. Food Chem Toxicol 2010;48:3308-15. [PMID: 20800087 DOI: 10.1016/j.fct.2010.08.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
131 Seo YS. [Transient elastography, true or false?]. Korean J Hepatol. 2009;15:431-437. [PMID: 20037261 DOI: 10.3350/kjhep.2009.15.4.431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
132 Hong S, Jung KH, Zheng H, Lee H, Suh J, Park I, Lee D, Hong S. The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats. Arch Pharm Res 2010;33:601-9. [DOI: 10.1007/s12272-010-0415-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
133 Frith J, Newton JL. Liver disease in older women. Maturitas 2010;65:210-4. [DOI: 10.1016/j.maturitas.2009.11.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
134 Kim SU, Choi GH, Han WK, Kim BK, Park JY, Kim DY, Choi JS, Yang SC, Choi EH, Ahn SH, Han KH, Chon CY. What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea. Liver Int 2010;30:268-74. [PMID: 19929903 DOI: 10.1111/j.1478-3231.2009.02172.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
135 Becker VR, Badiani RG, Lemos LB, Perez RM, Medina-Pestana JO, Lanzoni VP, Ferreira AP, Silva AE, Ferraz ML. Factors associated with the progression of hepatic fibrosis in end-stage kidney disease patients with hepatitis C virus infection. Eur J Gastroenterol Hepatol 2009;21:1395-9. [PMID: 19525852 DOI: 10.1097/MEG.0b013e328313bbc1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
136 Marra F, Galastri S, Aleffi S, Pinzani M. Stellate Cells. In: Dufour J, Clavien P, editors. Signaling Pathways in Liver Diseases. Berlin: Springer Berlin Heidelberg; 2010. pp. 41-68. [DOI: 10.1007/978-3-642-00150-5_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
137 Kireev RA, Tresguerres AC, Garcia C, Borras C, Ariznavarreta C, Vara E, Vina J, Tresguerres JA. Hormonal regulation of pro-inflammatory and lipid peroxidation processes in liver of old ovariectomized female rats. Biogerontology 2010;11:229-43. [PMID: 19633997 DOI: 10.1007/s10522-009-9242-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
138 Suzuki A, Abdelmalek MF. Nonalcoholic fatty liver disease in women. Womens Health (Lond). 2009;5:191-203. [PMID: 19245356 DOI: 10.2217/17455057.5.2.191] [Cited by in Crossref: 86] [Cited by in F6Publishing: 94] [Article Influence: 6.1] [Reference Citation Analysis]
139 Tofovic SP, Zhang X, Jackson EK, Zhu H, Petrusevska G. 2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats. Vascul Pharmacol 2009;51:190-7. [PMID: 19540933 DOI: 10.1016/j.vph.2009.06.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
140 Imaoka M, Kato M, Tago S, Gotoh M, Satoh H, Manabe S. Effects of estradiol treatment and/or ovariectomy on spontaneous hemorrhagic lesions in the pancreatic islets of Sprague-Dawley rats. Toxicol Pathol 2009;37:218-26. [PMID: 19332664 DOI: 10.1177/0192623308329283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
141 Sezaki H, Suzuki F, Kawamura Y, Yatsuji H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Miyakawa Y, Kumada H. Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads. Dig Dis Sci 2009;54:1317-24. [PMID: 18958621 DOI: 10.1007/s10620-008-0500-y] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 5.4] [Reference Citation Analysis]
142 Sezaki H, Suzuki F, Kawamura Y, Yatsuji H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Miyakawa Y, Kumada H. Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads. Dig Dis Sci 2009;54:1317-24. [PMID: 18958621 DOI: 10.1007/s10620-008-0500-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
143 Sharma NK, Sherker AH. Epidemiology, Risk Factors, and Natural History of Chronic Hepatitis C. In: Shetty K, Wu GY, editors. Chronic Viral Hepatitis. Totowa: Humana Press; 2010. pp. 33-70. [DOI: 10.1007/978-1-59745-565-7_2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
144 Rodrigues ADS, Dagli MLZ, Avanzo JL, Moraes HPD, Mackowiak II, Hernandez-blazquez FJ. Expression and distribution of connexin 32 in rat liver with experimentally induced fibrosis. Pesq Vet Bras 2009;29:353-7. [DOI: 10.1590/s0100-736x2009000400013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
145 Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India. J Gastroenterol Hepatol 2009;24:581-7. [PMID: 19032460 DOI: 10.1111/j.1440-1746.2008.05649.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
146 Kurahashi N, Inoue M, Iwasaki M, Tanaka Y, Mizokami M, Tsugane S; JPHC Study Group. Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population-based prospective cohort of Japanese men and women. Int J Cancer 2009;124:1644-9. [PMID: 19089922 DOI: 10.1002/ijc.24121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
147 Glaser SS, Gaudio E, Miller T, Alvaro D, Alpini G. Cholangiocyte proliferation and liver fibrosis. Expert Rev Mol Med. 2009;11:e7. [PMID: 19239726 DOI: 10.1017/s1462399409000994] [Cited by in Crossref: 137] [Cited by in F6Publishing: 147] [Article Influence: 9.8] [Reference Citation Analysis]
148 Kalra M, Mayes J, Assefa S, Kaul AK, Kaul R. Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J Gastroenterol 2008; 14(39): 5945-5961 [PMID: 18932272 DOI: 10.3748/wjg.14.5945] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 110] [Article Influence: 6.9] [Reference Citation Analysis]
149 Narciso-Schiavon JL, Schiavon LL, Carvalho-Filho RJ, Freire FC, Cardoso JR, Bordin JO, Silva AE, Ferraz ML. Anti-hepatitis C virus-positive blood donors: are women any different? Transfus Med. 2008;18:175-183. [PMID: 18598280 DOI: 10.1111/j.1365-3148.2008.00859.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
150 Ohara F, Nii A, Sakiyama Y, Tsuchiya M, Ogawa S. Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses. Dig Dis Sci 2008;53:2222-32. [PMID: 18095165 DOI: 10.1007/s10620-007-0112-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
151 Othman AA, Shoheib ZS, Abdel-Aleem GA, Shareef MM. Experimental schistosomal hepatitis: protective effect of coenzyme-Q10 against the state of oxidative stress. Exp Parasitol 2008;120:147-55. [PMID: 18640114 DOI: 10.1016/j.exppara.2008.06.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
152 Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008;48:606-13. [PMID: 18222014 DOI: 10.1016/j.jhep.2007.11.020] [Cited by in Crossref: 310] [Cited by in F6Publishing: 317] [Article Influence: 20.7] [Reference Citation Analysis]
153 Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72. [PMID: 18195085 DOI: 10.1152/physrev.00013.2007] [Cited by in Crossref: 1866] [Cited by in F6Publishing: 2001] [Article Influence: 124.4] [Reference Citation Analysis]
154 Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134:8-14. [PMID: 18166342 DOI: 10.1053/j.gastro.2007.11.053] [Cited by in Crossref: 107] [Cited by in F6Publishing: 119] [Article Influence: 7.1] [Reference Citation Analysis]
155 Shimizu I, Kohno N, Tamaki K, Shono M, Huang HW, He JH, Yao DF. Female hepatology: Favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J Gastroenterol 2007; 13(32): 4295-4305 [PMID: 17708600 DOI: 10.3748/wjg.v13.i32.4295] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 106] [Article Influence: 6.5] [Reference Citation Analysis]
156 Straub RH. The Complex Role of Estrogens in Inflammation. Endocrine Reviews 2007;28:521-74. [DOI: 10.1210/er.2007-0001] [Cited by in Crossref: 1122] [Cited by in F6Publishing: 1183] [Article Influence: 70.1] [Reference Citation Analysis]
157 Shimizu I, Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res 2007;37:239-47. [PMID: 17397511 DOI: 10.1111/j.1872-034X.2007.00032.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 4.5] [Reference Citation Analysis]
158 Shimizu I. Recent Therapeutic Developments in Hepatic Fibrosis. Fibrogenesis: Cellular and Molecular Basis. [DOI: 10.1007/0-387-26476-0_11] [Reference Citation Analysis]
159 Codes L, Asselah T, Cazals-Hatem D, Tubach F, Vidaud D, Paraná R, Bedossa P, Valla D, Marcellin P. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut 2007;56:390-5. [PMID: 17005762 DOI: 10.1136/gut.2006.101931] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 5.8] [Reference Citation Analysis]
160 Corpechot C, El Naggar A, Poupon R. Gender and liver: is the liver stiffness weaker in weaker sex? Hepatology 2006;44:513-4. [PMID: 16871581 DOI: 10.1002/hep.21306] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
161 Cheng X, Shimizu I, Yuan Y, Wei M, Shen M, Huang H, Urata M, Sannomiya K, Fukuno H, Hashimoto-Tamaoki T. Effects of estradiol and progesterone on tumor necrosis factor alpha-induced apoptosis in human hepatoma HuH-7 cells. Life Sci. 2006;79:1988-1994. [PMID: 16860828 DOI: 10.1016/j.lfs.2006.06.044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
162 Mcclung JM, Davis JM, Wilson MA, Goldsmith EC, Carson JA. Estrogen status and skeletal muscle recovery from disuse atrophy. Journal of Applied Physiology 2006;100:2012-23. [DOI: 10.1152/japplphysiol.01583.2005] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 5.5] [Reference Citation Analysis]
163 Ricchi M, Bertolotti M, Anzivino C, Carulli L, Canedi I, Bormioli ML, Tiozzo R, Croce MA, Lonardo A, Carulli N, Loria P. 17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures. J Gastroenterol Hepatol 2006;21:894-901. [PMID: 16704542 DOI: 10.1111/j.1440-1746.2006.04144.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
164 Feld JJ, Liang TJ. Hepatitis C -- identifying patients with progressive liver injury. Hepatology 2006;43:S194-206. [PMID: 16447261 DOI: 10.1002/hep.21065] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 3.8] [Reference Citation Analysis]
165 Itagaki T, Shimizu I, Cheng X, Yuan Y, Oshio A, Tamaki K, Fukuno H, Honda H, Okamura Y, Ito S. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 2005;54:1782-9. [PMID: 16284289 DOI: 10.1136/gut.2005.053278] [Cited by in F6Publishing: 41] [Reference Citation Analysis]
166 Itagaki T, Shimizu I, Cheng X, Yuan Y, Oshio A, Tamaki K, Fukuno H, Honda H, Okamura Y, Ito S. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 2005;54:1782-9. [PMID: 16284289 DOI: 10.1136/gut.2005.053278] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 4.2] [Reference Citation Analysis]
167 Yokoyama Y, Nimura Y, Nagino M, Bland KI, Chaudry IH. Current Understanding of Gender Dimorphism in Hepatic Pathophysiology1. Journal of Surgical Research 2005;128:147-56. [DOI: 10.1016/j.jss.2005.04.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
168 Rigamonti C, Andorno S, Maduli E, Capelli F, Boldorini R, Sartori M. Gender and liver fibrosis in chronic hepatitis: the role of iron status. Aliment Pharmacol Ther 2005;21:1445-51. [PMID: 15948811 DOI: 10.1111/j.1365-2036.2005.02517.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
169 Sakamoto M, Ueno T, Nakamura T, Sakata R, Hasimoto O, Torimura T, Sata M. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen. Eur J Clin Invest. 2005;35:220-225. [PMID: 15733078 DOI: 10.1111/j.1365-2362.2005.01476.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
170 Yajun Z, Hongshan C, Baoxi S, Dengbing Y, Jianhua S, Xinshun G, Li Y, Yi C. Translocation of Bax in rat hepatocytes cultured with ferric nitrilotriacetate. Life Sci. 2005;76:2763-2772. [PMID: 15808878 DOI: 10.1016/j.lfs.2004.07.035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
171 Zhou YJ, Yin DM, Chen HS, Shi JH, Sha BX, Wang X. Inhibitory effects of idoxifene on hepatic fibrosis in rats. Acta Pharmacol Sin 2005;26:581-6. [PMID: 15842777 DOI: 10.1111/j.1745-7254.2005.00082.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
172 Kang JS, Wanibuchi H, Morimura K, Puatanachokchai R, Salim EI, Hagihara A, Seki S, Fukushima S. Enhancement by estradiol 3-benzoate in thioacetamide-induced liver cirrhosis of rats. Toxicol Sci. 2005;85:720-726. [PMID: 15716488 DOI: 10.1093/toxsci/kfi113] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
173 Shih CC, Wu YW, Hsieh CC, Lin WC. Effect of Anoectochilus formosanus on fibrosis and regeneration of the liver in rats. Clin Exp Pharmacol Physiol. 2004;31:620-625. [PMID: 15479170 DOI: 10.1111/j.1440-1681.2004.04062.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
174 Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C, Poynard T. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2004;40:1426-33. [PMID: 15565616 DOI: 10.1002/hep.20463] [Cited by in Crossref: 194] [Cited by in F6Publishing: 177] [Article Influence: 10.2] [Reference Citation Analysis]
175 Sato R, Maesawa C, Fujisawa K, Wada K, Oikawa K, Takikawa Y, Suzuki K, Oikawa H, Ishikawa K, Masuda T. Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosis. Gut 2004;53:1001-9. [PMID: 15194652 DOI: 10.1136/gut.2003.027516] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
176 Liu QH, Li DG, Huang X, Zong CH, Xu QF, Lu HM. Suppressive effects of 17β-estradiol on hepatic fibrosis in CCl4-induced rat model. World J Gastroenterol 2004; 10(9): 1315-1320 [PMID: 15112349 DOI: 10.3748/wjg.v10.i9.1315] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
177 Lu G, Shimizu I, Cui X, Itonaga M, Tamaki K, Fukuno H, Inoue H, Honda H, Ito S. Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats. Life Sci. 2004;74:897-907. [PMID: 14659978 DOI: 10.1016/j.lfs.2003.08.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 2.8] [Reference Citation Analysis]
178 Schnur J, Oláh J, Szepesi A, Nagy P, Thorgeirsson SS. Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice. Eur J Gastroenterol Hepatol 2004;16:127-33. [PMID: 15075984 DOI: 10.1097/00042737-200402000-00002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 1.6] [Reference Citation Analysis]
179 Kondou H, Mushiake S, Etani Y, Miyoshi Y, Michigami T, Ozono K. A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo. J Hepatol 2003;39:742-8. [PMID: 14568256 DOI: 10.1016/s0168-8278(03)00377-5] [Cited by in Crossref: 71] [Cited by in F6Publishing: 79] [Article Influence: 3.6] [Reference Citation Analysis]
180 Rossi L, Leveri M, Gritti C, De Silvestri A, Zavaglia C, Sonzogni L, Silvestri L, Civardi E, Mondelli MU, Silini EM. Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients. J Hepatol 2003;39:564-70. [PMID: 12971967 DOI: 10.1016/s0168-8278(03)00355-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
181 Nakamura S, Yamada T, Hashimoto T, Takahashi S, Sogawa M, Ohara H, Nakazawa T, Sano H, Kuno A, Joh T, Nomura T, Arakawa T, Itoh M. Estradiol alleviates acinar cell apoptosis and chronic pancreatitis in male Wistar Bonn/Kobori rats. Pancreas 2003;26:e59-66. [PMID: 12657966 DOI: 10.1097/00006676-200304000-00024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
182 Inoue H, Shimizu I, Lu G, Itonaga M, Cui X, Okamura Y, Shono M, Honda H, Inoue S, Muramatsu M, Ito S. Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes. Dig Dis Sci 2003;48:570-80. [PMID: 12757172 DOI: 10.1023/a:1022553119715] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
183 Fernández I, Castellano G, de Salamanca RE, Colina F, de la Cámara AG, Morán MJ, Muñoz R, Solís-Herruzo JA. Porphyria cutanea tarda as a Predictor of Poor Response to Interferon Alfa Therapy in Chronic Hepatitis C. Scand J Gastroenterol 2003;38:314-9. [PMID: 28248596 DOI: 10.1080/00365520310000672a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
184 Tadic SD, Elm MS, Li HS, Van Londen GJ, Subbotin VM, Whitcomb DC, Eagon PK. Sex differences in hepatic gene expression in a rat model of ethanol-induced liver injury. J Appl Physiol (1985). 2002;93:1057-1068. [PMID: 12183503 DOI: 10.1152/japplphysiol.00568.2001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
185 Shimizu I. Impact of oestrogens on the progression of liver disease. Liver Int 2003;23:63-9. [PMID: 12640729 DOI: 10.1034/j.1600-0676.2003.00811.x] [Cited by in Crossref: 141] [Cited by in F6Publishing: 131] [Article Influence: 7.1] [Reference Citation Analysis]
186 Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Yanase K, Namisaki T, Imazu H, Fukui H. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 2002;36:850-60. [PMID: 12297832 DOI: 10.1053/jhep.2002.35625] [Cited by in Crossref: 151] [Cited by in F6Publishing: 159] [Article Influence: 7.2] [Reference Citation Analysis]
187 Liu XJ, Yang L, Mao YQ, Wang Q, Huang MH, Wang YP, Wu HB. Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, activation of cultured rat hepatic stellate cells. World J Gastroenterol 2002; 8(4): 739-745 [PMID: 12174389 DOI: 10.3748/wjg.v8.i4.739] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.8] [Reference Citation Analysis]
188 Liu Y, Shimizu I, Omoya T, Ito S, Gu XS, Zuo J. Protective effect of estradiol on hepatocytic oxidative damage. World J Gastroenterol 2002; 8(2): 363-366 [PMID: 11925626 DOI: 10.3748/wjg.v8.i2.363] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
189 Branch AD, Walewski JL. The coming impact of gene expression profiling on the diagnosis and treatment of HCV-associated liver disease. Antiviral Research 2001;52:173-9. [DOI: 10.1016/s0166-3542(01)00182-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
190 Shimizu I, Inoue H, Yano M, Shinomiya H, Wada S, Tsuji Y, Tsutsui A, Okamura S, Shibata H, Ito S. Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver 2001;21:342-9. [PMID: 11589771 DOI: 10.1034/j.1600-0676.2001.210507.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.3] [Reference Citation Analysis]
191 Zhou Y, Shimizu I, Lu G, Itonaga M, Okamura Y, Shono M, Honda H, Inoue S, Muramatsu M, Ito S. Hepatic stellate cells contain the functional estrogen receptor beta but not the estrogen receptor alpha in male and female rats. Biochem Biophys Res Commun. 2001;286:1059-1065. [PMID: 11527408 DOI: 10.1006/bbrc.2001.5479] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 2.2] [Reference Citation Analysis]
192 Omoya T, Shimizu I, Zhou Y, Okamura Y, Inoue H, Lu G, Itonaga M, Honda H, Nomura M, Ito S. Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress. Liver. 2001;21:183-191. [PMID: 11422781 DOI: 10.1034/j.1600-0676.2001.021003183.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 2.2] [Reference Citation Analysis]
193 Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol 2001;35:297-306. [PMID: 11580156 DOI: 10.1016/s0168-8278(01)00142-8] [Cited by in Crossref: 536] [Cited by in F6Publishing: 555] [Article Influence: 24.4] [Reference Citation Analysis]
194 Sakamoto M, Uen T, Nakamura T, Hashimoto O, Sakata R, Kin M, Ogata R, Kawaguch T, Torimura T, Sata M. Estrogen upregulates nitric oxide synthase expression in cultured rat hepatic sinusoidal endothelial cells. J Hepatol 2001;34:858-64. [PMID: 11451169 DOI: 10.1016/s0168-8278(01)00023-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
195 Seliger SL, Davis C, Stehman-Breen C. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens 2001;10:219-25. [PMID: 11224697 DOI: 10.1097/00041552-200103000-00010] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 4.1] [Reference Citation Analysis]
196 Pinzani M, Romanelli RG, Magli S. Progression of fibrosis in chronic liver diseases: time to tally the score. J Hepatol 2001;34:764-7. [PMID: 11434626 DOI: 10.1016/s0168-8278(01)00055-1] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
197 Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol 2001;34:730-9. [PMID: 11434620 DOI: 10.1016/s0168-8278(00)00097-0] [Cited by in Crossref: 511] [Cited by in F6Publishing: 515] [Article Influence: 23.2] [Reference Citation Analysis]
198 Shimizu I, Omoya T, Zhou Y, Itonaga M, Inoue H, Lu G, Okamura Y, Shono M, Honda H, Ito S. Antioxidant and Antiapoptotic Activities of a Tissue-Specific Selective Estrogen Receptor Modulator, Idoxifene, in Rat Fibrotic Liver and Cultured Rat Hepatocytes. Trends in Gastroenterology and Hepatology 2001. [DOI: 10.1007/978-4-431-67895-3_67] [Reference Citation Analysis]
199 Sartori M, Andorno S, Rigamonti C, Grossini E, Nicosia G, Boldorini R. Chronic hepatitis C is mild in menstruating women. J Gastroenterol Hepatol 2000;15:1411-7. [PMID: 11197052 DOI: 10.1046/j.1440-1746.2000.02368.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
200 Lee SH, Chae K, Nan J, Sohn DH. The increment of purine specific sodium nucleoside cotransporter mRNA in experimental fibrotic liver induced by bile duct ligation and scission. Arch Pharm Res 2000;23:613-9. [DOI: 10.1007/bf02975250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]